EUVIMEDEUVIMED entdecken
Crossref

Endogenous Nitric Oxide Releases In Situ for RNS/ROS Synergistic Cancer Therapy

Zichuang Xu, Qingzhi Luo, Yaqian He, Yuchu He, Xuwu Zhang, Jing Wang, Song Ni, Dawei Gao, Desong Wang

Advanced Functional Materials · 2024-04 · 34 (17)

DOI: 10.1002/adfm.202314536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 02.01.2024. Verfasst von Zichuang Xu und 8 weiteren Autor:innen. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Natural Science Foundation of Hebei Province, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gas therapy, represented by nitric oxide (NO), has shown a powerful anti‐tumor effect. However, current NO therapy relies on NO precursors, which are often released prematurely during in vivo delivery, resulting in poor targeting and obvious toxic side effects. Herein, a core/shell‐structured nanocatalyst is designed and prepared to catalyze the generation of NO in tumor without introduction of NO donor. In this system, C‐Z@CM is prepared by coating the octahedron of Cu‐MOF with a nano‐ZnO, and camouflaging homologous tumor cell membrane. After the nanomedicine is taken up by tumor cells, ZnO reacts in situ with endogenous S‐nitrosoglutathione (GSNO), which is highly expressed in tumors, to continuously and stably generate NO. In addition, the dispersed copper ions in C‐Z@CM acts as the catalytic active centers of the Fenton‐like reaction, which catalyzes H 2 O 2 to generate a large number of hydroxyl radicals ( • OH). Importantly, the cascade of NO and reactive oxygen species (ROS) leads to the massive production of more lethal reactive nitrogen species (RNS), further enhancing the therapeutic effect. Catalytic production of high concentrations of NO in situ in the tumor, combined with the cascade generation of ROS and RNS, accompanied by glutathione (GSH) depletion, achieving effective tumor suppression.

Förderung

  • Natural Science Foundation of Hebei Province
  • National Natural Science Foundation of China

Zitieren

APA

Xu, Z., Luo, Q., He, Y., He, Y., Zhang, X., Wang, J., Ni, S., Gao, D., & Wang, D. (2024). Endogenous Nitric Oxide Releases In Situ for RNS/ROS Synergistic Cancer Therapy. Advanced Functional Materials, 34(17). https://doi.org/10.1002/adfm.202314536

Vancouver

Xu Z, Luo Q, He Y, He Y, Zhang X, Wang J, et al. Endogenous Nitric Oxide Releases In Situ for RNS/ROS Synergistic Cancer Therapy. Advanced Functional Materials. 2024;34(17). doi:10.1002/adfm.202314536

BibTeX
@article{Xu2024,
  author = {Xu, Zichuang and Luo, Qingzhi and He, Yaqian and He, Yuchu and Zhang, Xuwu and Wang, Jing and Ni, Song and Gao, Dawei and Wang, Desong},
  title = {Endogenous Nitric Oxide Releases In Situ for RNS/ROS Synergistic Cancer Therapy},
  journal = {Advanced Functional Materials},
  year = {2024},
  volume = {34},
  number = {17},
  doi = {10.1002/adfm.202314536}
}
Kostenlos starten →